PureCycle Technologies
PCTNASDAQUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $2.13 Prior regular-session close from the quote source.
- $1.96–$2.21 Regular-session low and high so far today.
- 5.5M Regular-session shares traded · Nov 11, 4:00 PM ET.
- Feb 25 projected Projected for 2027-02-25 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
- $1.60–$14.20 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own PCT if PureCycle can create durable value by converting municipal/industrial polypropylene waste into a branded, premium recycled polypropylene (PureFive) at commercial scale, capturing price premiums and long-term offtakes as regulatory and brand demand forces recycled-content adoption.
PCT price history
Loading recent earnings…
Investment thesis
What must happen next
Successful commissioning and ramp of Purification/Feed PreP plants will convert installed capacity into recurring resin sales, driving material revenue growth.HoldingMateriality: High
FY2025 Revenues of 8,355,000 USD (first non-zero annual revenue after prior years at 0) show initial commercial sales tied to plant activity. If plants ramp, revenue scales and the company can demonstrate unit economics; if they do not, the business remains a capital-consuming prototype and share value collapses.
Watch: Feedstock supply interruptions or local feedstock price spikes that limit throughput (raw material price risk described in MD&A).
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
FY2025 Revenues of 8,355,000 USD (first non-zero annual revenue after prior years at 0) show initial commercial sales tied to.
Open source ↗Achieving scale at multiple purification plants will materially reduce per-unit production costs and convert large operating losses toward breakeven (operating income improvement) as fixed costs spread and process yields improve.WeakeningMateriality: High
Large asset base increases (assets rose toward 922,666,000 USD in FY2025) consistent with capital deployed to build capacity that should enable scale economics. Margin recovery determines whether revenue growth becomes cash-generative or merely increases capital requirements; failure to reduce operating losses means perpetual dilution or restructuring.
Watch: Sustained low crude oil/virgin-PP prices that make virgin resin materially cheaper than recycled resin, compressing margins (commodity market risk in MD&A).
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Large asset base increases (assets rose toward 922,666,000 USD in FY2025) consistent with capital deployed to build capacity that should.
Open source ↗Existing cash balances must fund the near-term ramp; without material positive operating cash flow or new financing, the company will need to raise capital or slow projects.StrengtheningMateriality: Medium
Cash and cash equivalents of 156,694,000 USD at 2025 year-end. If cash is sufficient for the planned ramp, management can execute; if not, equity dilution, project delays, or asset sales are likely and would damage value for existing shareholders.
Watch: Inability to access capital markets on acceptable terms (market sentiment or equity dilution risk).
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Regulatory mandates for recycled content and corporate sustainability commitments will sustain baseline demand and allow PureFive to command a pricing premium versus commodity virgin polypropylene.HoldingMateriality: Medium
MD&A cites 'shifting market expectations toward sustainable sourcing' and 'certain regulatory developments in support of plastic recycling' as demand supports. Regulatory and brand-driven demand reduces price elasticity and defends margins; absent such tailwinds, PureCycle competes mainly on cost with commodity virgin PP.
Watch: Delays, rollbacks, or weaker-than-expected scope in recycled-content mandates from key jurisdictions.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
MD&A cites 'shifting market expectations toward sustainable sourcing' and 'certain regulatory developments in support of plastic recycling' as demand supports.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Successful commissioning and ramp of Purification/Feed PreP plants will convert installed capacity into recurring resin sales, driving material revenue growth. If plants ramp, revenue scales and the company can demonstrate unit economics; if they do not, the business remains a capital-consuming prototype and share value collapses.
Achieving scale at multiple purification plants will materially reduce per-unit production costs and convert large operating losses toward breakeven (operating income improvement) as fixed costs spread and process yields improve. Margin recovery determines whether revenue growth becomes cash-generative or merely increases capital requirements; failure to reduce operating losses means perpetual dilution or restructuring.
Existing cash balances must fund the near-term ramp; without material positive operating cash flow or new financing, the company will need to raise capital or slow projects. If cash is sufficient for the planned ramp, management can execute; if not, equity dilution, project delays, or asset sales are likely and would damage value for existing shareholders.
Regulatory mandates for recycled content and corporate sustainability commitments will sustain baseline demand and allow PureFive to command a pricing premium versus commodity virgin polypropylene. Regulatory and brand-driven demand reduces price elasticity and defends margins; absent such tailwinds, PureCycle competes mainly on cost with commodity virgin PP.
All standing thesis claims
Original report summary
PureCycle can create durable value by converting municipal/industrial polypropylene waste into a branded, premium recycled polypropylene (PureFive) at commercial scale, capturing price premiums and long-term offtakes as regulatory and brand demand forces recycled-content adoption.
Bull case and bear case
Bull case and bear case for PureCycle Technologies
Where the evidence on PureCycle Technologies disagrees: Mixed on the latest evidence (Nov 10, 2026). Of its 4 thesis points, 1 strengthening, 2 holding and 1 weakening.
Bull case: what the evidence supports
Successful commissioning and ramp of Purification/Feed PreP plants will convert installed capacity into recurring resin sales, driving material revenue growth.
Existing cash balances must fund the near-term ramp; without material positive operating cash flow or new financing, the company will need to raise capital or slow projects.
Regulatory mandates for recycled content and corporate sustainability commitments will sustain baseline demand and allow PureFive to command a pricing premium versus commodity virgin polypropylene.
Bear case: what the evidence questions
Achieving scale at multiple purification plants will materially reduce per-unit production costs and convert large operating losses toward breakeven (operating income improvement) as fixed costs spread and process yields improve.
Thesis-Break Engine
What has broken in PureCycle Technologies’s thesis
Each break OptimistFi flagged on PureCycle Technologies, dated — with what has historically followed the same kind of break across the market, not a forecast for PureCycle Technologies.
- CEO / officer changecondition set before this filing
Across all companies, this kind of break has happened 16,849 times before. Those stocks trailed comparable companies by a median of 2% over the next six months, and 38% of them trailed it by 10 points or more.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedReported results of operations (earnings release).
PureCycle Technologies filed an SEC 8-K on 2026-11-04: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
- MixedEntered a material definitive agreement.
PureCycle Technologies filed an SEC 8-K on 2026-08-31: Entered a material definitive agreement. It is a dated development that tests the current thesis.
- MixedReported results of operations (earnings release).
PureCycle Technologies filed an SEC 8-K on 2026-08-06: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- Feedstock supply interruptions or local feedstock price spikes that limit throughput (raw material price risk described in MD&A).
- Sustained low crude oil/virgin-PP prices that make virgin resin materially cheaper than recycled resin, compressing margins (commodity market risk in MD&A).
- Inability to access capital markets on acceptable terms (market sentiment or equity dilution risk).
- Delays, rollbacks, or weaker-than-expected scope in recycled-content mandates from key jurisdictions.
PCT news
Loading headlines…
Financial statements
PCT income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
PCT: quick answers
- When does PureCycle Technologies (PCT) report earnings next?
- PureCycle Technologies's next results are projected for February 25, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on November 4, 2026. Earnings calendar
- What is PCT's short interest?
- As of October 30, 2026, 69.3M PCT shares were sold short, 34.5% of its shares outstanding, up 6.2% from the count before. At the stock's average daily volume that is 11 days to cover. FINRA publishes the count twice a month. PCT short interest history
- Which well-known investors own PCT?
- 1 of the 37 well-known funds tracked here reported PCT shares in their latest 13F filing. By share of the fund's portfolio: Duquesne Family Office (Stanley Druckenmiller), 0.4%. Fund portfolios
PCT in well-known investors’ portfolios
1 of 37 funds reported PCT shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.
| Fund | Of its portfolio | Value | Change | Quarter |
|---|---|---|---|---|
| Stanley DruckenmillerDuquesne Family Office | 0.42% | $21.7M | +178.4% | Q2 2026 |
